Pfizer’s Lorbrena scores US priority review
admin 4th January 2021 Uncategorised 0Drug is being reviewed for ALK-positive lung cancer
More: Pfizer’s Lorbrena scores US priority review
Source: News
Drug is being reviewed for ALK-positive lung cancer
More: Pfizer’s Lorbrena scores US priority review
Source: News
Fierce Pharma Politics—Judge blocks Trump's 'most favored nation' drug pricing rule
Fierce Pharma Politics—Judge blocks Trump's 'most favored nation' d
Feds consider half-doses of Moderna COVID-19 vaccine to stretch supplies, as U.K. spaces out Pfizer, AstraZeneca shots
Feds consider half-doses of Moderna COVID-19 vaccine to stretch suppl
Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 with nearly 600 price hikes
Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 wit
© 1994 - 2021 B.M. Pharmaceuticals